AIL
ICPT

AGF Investments LLC’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

AGF Investments LLC’s Portfolio ICPT Stock Details ICPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-76
Closed -$9K – 818
2017
Q2 		$9K Sell
76
-4
-5% -$463 ﹤0.01% 645
2017
Q1 		$9K Sell
80
-12
-13% -$1.4K ﹤0.01% 657
2016
Q4 		$10K Buy
+92
New +$11K ﹤0.01% 652

Other funds holding ICPT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
SM
Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

AGF Investments LLC's ICPT Position: Q3 2017 in Review

AGF Investments LLC sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q3 2017, closing a stake of 76 shares — an estimated $9K sold.

AGF Investments LLC first reported a position in ICPT in Q4 2016 and held it in 3 quarters. The position peaked at $10K in Q4 2016. 155 funds tracked by Wall St. Rank hold ICPT as of Q3 2017.

  • AGF Investments LLC reported no remaining Intercept Pharmaceuticals, Inc. position as of Q3 2017 after selling out during the quarter.
  • AGF Investments LLC sold 76 Intercept Pharmaceuticals, Inc. shares in Q3 2017, an estimated $9K.
  • AGF Investments LLC first reported a position in Intercept Pharmaceuticals, Inc. in Q4 2016 and held it in 3 quarters.
  • AGF Investments LLC's Intercept Pharmaceuticals, Inc. position peaked at $10K in Q4 2016.
  • 155 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q3 2017.

Based on AGF Investments LLC's 13F filing for Q3 2017, filed 9 Nov 2017.